title: Monoclonal antibodies for septic shock: in or out of the barn door?
authors.affiliation: Thomas Jefferson University Hospital, Philadelphia, PA 19107-5099.
authors.forename: D B
authors.initials: DB
authors.lastname: Nash
authors.forename: N E
authors.initials: NE
authors.lastname: Johnson
authors.forename: J E
authors.initials: JE
authors.lastname: Gottlieb
authors.forename: P H
authors.initials: PH
authors.lastname: Vlasses
mesh_terms: D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D016470:Bacteremia / Q000191:economics* / Q000401:mortality / Q000628:therapy; D014487:Centers for Medicare and Medicaid Services, U.S.; D002985:Clinical Protocols; D003362:Cost-Benefit Analysis; D003953:Diagnosis-Related Groups; D016527:Drug Costs; D004363:Drug Utilization / Q000191:economics / Q000592:standards*; D016905:Gram-Negative Bacterial Infections / Q000191:economics* / Q000401:mortality / Q000628:therapy; D006746:Hospital Bed Capacity, 500 and over; D006801:Humans; D010606:Pharmacy and Therapeutics Committee; D015143:Philadelphia; D012051:Reimbursement Mechanisms; D012772:Shock, Septic / Q000191:economics* / Q000401:mortality / Q000628:therapy; D014481:United States
chemical_list: D000911:Antibodies, Monoclonal